T1	PROC 1 26	Valoración de la eficacia
#1	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
T2	PROC 30 59	tratamiento tópico prolongado
T3	PROC 65 73	prevenir
#2	AnnotatorNotes T3	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T4	PROC 87 92	LASIK
#3	AnnotatorNotes T4	C0752094; Keratomileusis, Laser In Situ; Therapeutic or Preventive Procedure
T5	DISO 93 107	hipermetrópico
#4	AnnotatorNotes T5	C0020490; Hyperopia; Disease or Syndrome
T6	PROC 143 184	tratamiento corticoideo tópico prolongado
T7	PROC 198 206	operados
#5	AnnotatorNotes T7	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T8	PROC 210 215	LASIK
#6	AnnotatorNotes T8	C0752094; Keratomileusis, Laser In Situ; Therapeutic or Preventive Procedure
T9	DISO 216 230	hipermetrópico
#7	AnnotatorNotes T9	C0020490; Hyperopia; Disease or Syndrome
T10	PROC 267 309	estudio prospectivo observador enmascarado
#8	AnnotatorNotes T10	C0033522; Prospective Studies; Research Activity + C0242570; Single-Blind Study; Research Activity
T11	PROC 407 431	asignados aleatoriamente
#9	AnnotatorNotes T11	C0034656; Randomization; Research Activity
T12	CHEM 558 572	fluorometalona
#10	AnnotatorNotes T12	C0016351; fluorometholone; Organic Chemical · Pharmacologic Substance
T13	PROC 334 347	cirugía LASIK
#11	AnnotatorNotes T13	C2095814; LASIK surgery; Therapeutic or Preventive Procedure
T14	DISO 386 399	hipermetropía
#12	AnnotatorNotes T14	C0020490; Hyperopia; Disease or Syndrome
T15	PROC 442 472	tratamiento tópico corticoideo
T16	CHEM 461 472	corticoideo
#13	AnnotatorNotes T16	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T17	CHEM 474 486	dexametasona
#14	AnnotatorNotes T17	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T18	CHEM 525 537	dexametasona
#15	AnnotatorNotes T18	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T19	DISO 1058 1078	regresión refractiva
T20	ANAT 703 707	ojos
#16	AnnotatorNotes T20	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T21	PROC 1084 1089	LASIK
#17	AnnotatorNotes T21	C0752094; Keratomileusis, Laser In Situ; Therapeutic or Preventive Procedure
T22	DISO 1090 1104	hipermetrópico
#18	AnnotatorNotes T22	C0020490; Hyperopia; Disease or Syndrome
T23	PROC 1151 1181	tratamiento corticoideo tópico
T24	DISO 74 83	regresión
#19	AnnotatorNotes T24	C0544452; Disease remission; Finding | C0597370; remission/regression; Pathologic Function
T25	CHEM 155 166	corticoideo
#20	AnnotatorNotes T25	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T26	CHEM 1163 1174	corticoideo
#21	AnnotatorNotes T26	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T27	Route 42 48	tópico
#22	AnnotatorNotes T27	C1522168; Topical Route of Drug Administration; Functional Concept
T28	Route 167 173	tópico
#23	AnnotatorNotes T28	C1522168; Topical Route of Drug Administration; Functional Concept
T29	LIVB 188 197	pacientes
#24	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	LIVB 311 320	Pacientes
#25	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Route 454 460	tópico
#26	AnnotatorNotes T31	C1522168; Topical Route of Drug Administration; Functional Concept
T32	Duration 488 498	una semana
T33	LIVB 500 513	grupo control
#27	AnnotatorNotes T33	C0009932; Control Groups; Group
T34	Duration 517 523	un mes
T35	Duration 538 555	la primera semana
T36	Date 773 786	preoperatorio
#28	AnnotatorNotes T36	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T39	Route 1175 1181	tópico
#29	AnnotatorNotes T39	C1522168; Topical Route of Drug Administration; Functional Concept
T40	Duration 937 948	los 3 meses
T41	Duration 573 592	las tres siguientes
T37	LIVB 855 868	grupo estudio
#30	AnnotatorNotes T37	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T42	LIVB 993 1006	grupo estudio
#31	AnnotatorNotes T42	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T38	LIVB 601 614	grupo estudio
#32	AnnotatorNotes T38	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T43	LIVB 723 730	estudio
#33	AnnotatorNotes T43	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T44	LIVB 733 740	control
#34	AnnotatorNotes T44	C0009932; Control Groups; Group
T45	LIVB 871 878	control
#35	AnnotatorNotes T45	C0009932; Control Groups; Group
T46	LIVB 1009 1016	control
#36	AnnotatorNotes T46	C0009932; Control Groups; Group
T47	PROC 616 640	Se comparó la refracción
#37	AnnotatorNotes T47	C0430943; Refraction assessment; Diagnostic Procedure
R1	Has_Route_or_Mode Arg1:T2 Arg2:T27	
R2	Before Arg1:T3 Arg2:T24	
R3	Before Arg1:T2 Arg2:T24	
R6	Used_for Arg1:T25 Arg2:T6	
R7	Has_Route_or_Mode Arg1:T25 Arg2:T28	
R8	Experiences Arg1:T29 Arg2:T7	
R9	Used_for Arg1:T29 Arg2:T6	
R10	Experiences Arg1:T29 Arg2:T8	
R11	Experiences Arg1:T29 Arg2:T9	
R13	Before Arg1:T8 Arg2:T6	
R14	Experiences Arg1:T30 Arg2:T13	
T48	Quantifier_or_Qualifier 370 374	baja
T49	Quantifier_or_Qualifier 377 385	moderada
R15	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T49	
R16	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T48	
R17	Experiences Arg1:T30 Arg2:T14	
R20	Has_Route_or_Mode Arg1:T17 Arg2:T31	
R21	Has_Duration_or_Interval Arg1:T17 Arg2:T32	
R22	Used_for Arg1:T17 Arg2:T15	
R23	Experiences Arg1:T33 Arg2:T15	
R18	Has_Duration_or_Interval Arg1:T17 Arg2:T34	
R19	Experiences Arg1:T38 Arg2:T15	
R24	Has_Duration_or_Interval Arg1:T12 Arg2:T41	
R25	Has_Duration_or_Interval Arg1:T18 Arg2:T35	
R26	Used_for Arg1:T12 Arg2:T15	
R27	Used_for Arg1:T18 Arg2:T15	
R28	Has_Route_or_Mode Arg1:T18 Arg2:T31	
R29	Has_Route_or_Mode Arg1:T12 Arg2:T31	
T50	CONC 746 766	equivalente esférico
R30	Overlap Arg1:T50 Arg2:T36	
T51	PROC 907 917	refracción
#38	AnnotatorNotes T51	C0430943; Refraction assessment; Diagnostic Procedure
R31	Overlap Arg1:T51 Arg2:T40	
R32	Experiences Arg1:T42 Arg2:T51	
R33	Experiences Arg1:T46 Arg2:T51	
R34	After Arg1:T19 Arg2:T21	
T52	Neg_cue 1106 1108	no
T53	Quantifier_or_Qualifier 1120 1129	modulable
A1	Assertion T53 Negated
R36	Negation Arg1:T52 Arg2:T53	
R37	Used_for Arg1:T26 Arg2:T23	
R38	Has_Route_or_Mode Arg1:T26 Arg2:T39	
R40	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T53	
R41	Experiences Arg1:T30 Arg2:T15	
R42	Experiences Arg1:T38 Arg2:T12	
R43	Experiences Arg1:T30 Arg2:T17	
R44	Experiences Arg1:T38 Arg2:T18	
R45	Before Arg1:T4 Arg2:T2	
R49	Before Arg1:T11 Arg2:T15	
R50	Before Arg1:T21 Arg2:T23	
R51	Before Arg1:T13 Arg2:T15	
#39	AnnotatorNotes T49	C0205081; Moderate (severity modifier); Qualitative Concept
#40	AnnotatorNotes T48	C0205251; low; Qualitative Concept 
A2	Experiencer T29 Patient
A3	Experiencer T30 Patient
A4	Experiencer T33 Patient
A5	Experiencer T38 Patient
A6	Experiencer T43 Patient
A7	Experiencer T44 Patient
A8	Experiencer T37 Patient
A9	Experiencer T45 Patient
A10	Experiencer T46 Patient
A11	Experiencer T42 Patient
